Human Genome Diversity Project

The October 14 issue of The Scientist reporting on the controversy plaguing the proposed Human Genome Diversity Project (HGDP) [K.Y. Kreeger, page 1] gives the mistaken impression that the Rural Advancement Foundation International (RAFI) has "softened" its views in opposition to the proposed HGDP. Nothing could be further from the truth. As I said in testimony before the National Academy of Sciences committee on September 16: "RAFI believes that moral, ethical, and legal issues have not been a

Written byHope Shand
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The October 14 issue of The Scientist reporting on the controversy plaguing the proposed Human Genome Diversity Project (HGDP) [K.Y. Kreeger, page 1] gives the mistaken impression that the Rural Advancement Foundation International (RAFI) has "softened" its views in opposition to the proposed HGDP. Nothing could be further from the truth. As I said in testimony before the National Academy of Sciences committee on September 16:

To date, the HGDP has been formally opposed in more than 20 declarations issued by indigenous peoples worldwide. It has been condemned by the European Parliament. The United Nations Educational, Scientific and Cultural Organization (UNESCO) has declined to endorse the HGDP. We don't believe the individuals associated with the HGDP are bad people, we just think the project is a very bad idea.

Given the international controversy and unresolved issues surrounding the HGDP, we believe that it would be a grave mistake for the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies